Evidence map›Paper›PMID 39742006›Full record

Observational studyCardiovascular therapeutics2024

Achievement of LDL-Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA-AP Study: LDL-Cholesterol Goals in Primary Care.

Sergio Cinza-Sanjurjo, Vivencio Barrios, David Fierro-González, Jose Polo-García, Vicente Pallarés-Carratalá

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Cardiovascular therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sergio Cinza-SanjurjoMilladoiro Health Centre Santiago de Compostela Health Area, Santiago de Compostela, Spain.ORCID https://orcid.org/0000-0002-4486-2820
Vivencio BarriosCardiology Department, H Ramón y Cajal 28034, Madrid, Spain.ORCID https://orcid.org/0000-0001-6135-7685
David Fierro-GonzálezArmunia Health Centre, León, Spain.
Jose Polo-GarcíaCasar de Cáceres Health Centre, Cáceres, Spain.ORCID https://orcid.org/0000-0002-3655-7180
Vicente Pallarés-CarrataláDepartment of Medicine Universitat Jaume I 12071, Castellón, Spain.ORCID https://orcid.org/0000-0002-2985-6078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersCholesterol, LDLDyslipidemiasHeart Disease Risk FactorsPrimary Health CareAgedAnticholesteremic AgentsCardiovascular DiseasesCross-Sectional StudiesFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsMaleMiddle AgedRisk AssessmentAnticholesteremic AgentsBiomarkersCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agentscardiovascular riskLDL-cholesterol goalslipid-lowering therapyprimary care

Identifiers

PMID39742006
PMCPMC11236467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.